| . | |
|
|
|
PACI is very delighted to announce that Kia Bowman, who was diagnosed with Large Diffuse B-Cell Lymphoma and had been patiently waiting for a marrow transplant, found her match! The marrow transplant was a huge success! With the help of all of you who assisted us through the process, Kia will continue to live her life happily in the company of her loving family and friends.
On October 9th, 2011, PACI held its 4th Annual Cancer Awareness Seminar at the Skirball Cultural Center . The seminar was mainly aimed at the Persian American community. Leading physicians, each in their own field of expertise, presented the most enlightening, informative, and practical advice on thyroid cancer (Dr. Armando Guiliano), breast cancer (Dr. Homayoon Sanati) and hematology (Dr. Sepehr Rokhsar). The importance of proper nutrition in prevention of cancer was highly emphasized by Professor Parviz Ghadirian. Nowadays, prevention, early detection, treatment, and healthy nutrition increase cancer survivor rates.
The event was an absolute success with a full house. The audience was particularly touched when Mrs. Sadler, the PACI chair founder and a cancer survivor herself, asked all the fellow cancer survivors to the stage. They all received a standing ovation; and the audience was moved by so many radiantly beautiful and gracious survivors.
Mr. John Paley, General Manager of 670AM KIRN Radio Iran, a cancer survivor himself, presented a $12,000 check on behalf of PACI to Be The Match, the National Marrow Donor Program. The funds donated were raised through the generous contribution of the general public, which pay for the marrow test kits, in registering possible donors who help save lives. The audience had an amazing afternoon filled with education and entertainment. The latter of which was by an outstanding live performance by the talented Arash Avin.Good News! PACI is proud to share articles written by one of our board members,
Breast Cancer Advisor, Dec. 2011
Breast Cancer Advisor, Jan. 2012
Dr. Silvana Martino D. O., FACOI is the Director of Breast Cancer Research and Education for The Angeles Clinic Foundation. She is board certified in internal medicine and medical oncology. Dr. Martino has specialized in the treatment and research of breast cancer for over three decades. She is a nationally recognized leader in the field of breast cancer. Her body of work has included research in breast cancer prevention, early breast cancer and metastatic disease. Dr. Martino has conducted and coordinated large national and international studies which have resulted in changing the standard of care worldwide.
|
Biology Basics
In this issue, I want to give you a historical perspective on how our understanding of the spread of breast cancer has changed and the impact that this has had on how we treat it. It was originally believed that breast cancer started in the breast. Once the breast was filled by it, it then would move into the neighboring lymph nodes. After they were occupied, the cancer would then spill into the blood system and from there to other parts of the body. (Full Article)
What's New?
Approximately 15 to 20 percent of breast cancers are HER2/neu positive. These cancers tend to be a bit more aggressive. The recognition of the HER2/neu receptor resulted in a major advance. Once it was identified, we were able to search for drugs that specifically targeted this receptor. The drug Herceptin was the first of these therapies. Its first use was in advanced disease where Herceptin was found to be of benefit both when given alone and also when combined with other therapies. The next step was to see if this drug was also of benefit in early breast cancer. (Full Article)
Guest Writter
Arnold L. Vinstein, MD "Imaging to Screen Women for Breast Cancer"
Although the controversy as to the appropriate interval and age for screening women with mammography continues in the press, the longstanding position of the American Cancer Society, the American College of Surgeons and the Society for Breast Imaging is that women of average risk begin annual screening mammography at age 40. The use of other screening tests, such as breast thermography and ultrasound, is more controversial primarily due to the excessive number of false positive results (a finding that suggests an abnorabnormality is present but is benign on further testing). (Full Article)
Page 1 of 3
AWARDS and CERTIFICATES
